Navigation Links
Dragon to Present at BioContact Quebec 2008
Date:9/25/2008

VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced that Ms. Maggie Deng, Chief Operating Officer and Mr. Garry Wong, Chief Financial Officer will present at 9:30 a.m. ET on Friday, October 3, 2008 at BioContact Quebec 2008 at the Chateau Frontenac hotel in Quebec City, Canada.

Ms. Maggie Deng and Mr. Garry Wong will present Dragon Pharma's business overview including product lines, competitive strengths, and key growth strategies.

BioContact Quebec 2008 is a biopharmaceutical partnership symposium that brings together over 1,200 participants from biopharmaceutical companies to present various sectors and disciplines of their companies. The conference will be held on October 1-3, for more information about the conference, please visit http://www.biocontact.qc.ca/english/default.html.

About Dragon Pharmaceutical Inc.

Dragon Pharmaceutical, headquartered in Vancouver, Canada, is a leading manufacturer and distributor of a broad line of high-quality antibiotic products including 7-ACA, a key intermediate to produce cephalosporin antibiotics, clavulanic acid, and formulated cephalosporin antibiotic drugs. Dragon is the third largest 7-ACA producer and the first manufacturer and market leader of clavulanic acid products in China. Dragon utilizes its nationwide sales distribution network, close customer relationships, understanding of local markets and customer needs and low cost structure to outperform its international and domestic peers. With an annual capacity of 780 tons, Dragon is the largest exporter of 7-ACA in China. To learn more about Dragon Pharmaceutical Inc., please visit http://www.dragonpharma.com.


'/>"/>
SOURCE Dragon Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dragon Pharma Announces Results of the Annual General Meeting
2. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
3. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
4. Dragon Pharma announces 2007 full year financial results
5. Dragon retains leading investor relations firm
6. Dragon announces new product launch; increase in annual production output capacity
7. Dragon Announces R&D Achievement in Biotech Manufacturing Process
8. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Air Transport Association Applauds House of Representatives on Decision to Withhold Biometric Collection Funding
11. AEterna Zentaris to Present at BioContact Quebec on October 2, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Biology News(10 mins):